2009
DOI: 10.1016/j.ophtha.2008.09.036
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Intravitreal Bevacizumab Injection on Aqueous Humor Cytokine Levels in Clinically Significant Macular Edema

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
64
2

Year Published

2009
2009
2021
2021

Publication Types

Select...
5
3
2

Relationship

0
10

Authors

Journals

citations
Cited by 98 publications
(70 citation statements)
references
References 32 publications
4
64
2
Order By: Relevance
“…Previous studies have shown that aqueous MCP-1 levels increase as diabetic retinopathy progresses [25] and that MCP-1 levels are elevated in eyes with DME [26]. In addition, there is a report demonstrating the relation of MCP-1 with DME [16,27]. Our study showed that MCP-1 is thought to play a role in CME development.…”
Section: Cystoid Macular Edemasupporting
confidence: 64%
“…Previous studies have shown that aqueous MCP-1 levels increase as diabetic retinopathy progresses [25] and that MCP-1 levels are elevated in eyes with DME [26]. In addition, there is a report demonstrating the relation of MCP-1 with DME [16,27]. Our study showed that MCP-1 is thought to play a role in CME development.…”
Section: Cystoid Macular Edemasupporting
confidence: 64%
“…Clinically, intravitreal triamcinolone acetonide, an anti-inflamatory steroids, is more effective for reduction of diabetic macular edema than intravitreal bevacizumab, a VEGF antibody [21]. Also, a recent report suggested that the pathogenesis of diabetic macular edema is more closely related with IL-6 and monocyte chemoattractant protein (MCP)-1 than VEGF because persistent diabetic macular edema after intravitreal bevacizumab showed higher level of IL-6 and MCP-1 in spite of lower level of VEGF [22].…”
Section: Discussionmentioning
confidence: 99%
“…In recent years, increased cytokine levels in AqH have been reported to be associated with pathogenesis and intraocular alteration in various ocular diseases; FECD, 22,27 graft rejection, 28,29 uveitis, [30][31][32] glaucoma, 19,32 AMD, 33,34 and retinal vein occlusion. [35][36][37] Maier et al 28 evaluated IL-2, IL-4, IL-5, IL-10, and IFN-c levels in 18 AqH samples that were collected at the time of PKP and reported that the cytokine levels in AqH were predictive of graft rejection.…”
Section: Figurementioning
confidence: 99%